Drug Profile
Insulin oral - Diabetology
Alternative Names: Capsulin; Capsulin IR; Capsulin OAD; DTY001Latest Information Update: 21 Jan 2022
Price :
$50
*
At a glance
- Originator Diabetology
- Class Antihyperglycaemics; Hepatoprotectants; Insulins; Pancreatic hormones
- Mechanism of Action Ornithine decarboxylase stimulants; Phosphokinase stimulants; Tyrosine aminotransferase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II Type 1 diabetes mellitus; Type 2 diabetes mellitus
Most Recent Events
- 10 Dec 2015 Diabetology plans a phase IIb trial for Type-2 diabetes mellitus
- 07 Aug 2015 Phase-II development for Type 1 diabetes mellitus and Type 2 diabetes mellitus is ongoing in United Kingdom
- 30 May 2011 Insulin oral is still in phase II trials for Type-1 and Type-2 diabetes mellitus in United Kingdom